Alexander Hardy, CEO, Genentech: Is Business Going to Save the World?
发布时间 2020-05-22 02:21:35 来源
摘要
Alexander Hardy, CEO, Genentech, was interviewed by Professor Brian Lowery for the Stanford GSB Business and Society class. In the interview they discussed the role of the pharma and biotech industries in addressing the COVID-19 pandemic.
Before becoming CEO, Alexander Hardy was head of Global Product Strategy, Roche Pharmaceuticals and served in a number of key leadership positions across Genentech and Roche for over 13 years. Hardy led cross-functional teams to develop and launch new medicines and indications in more than 100 countries worldwide. He also co-chaired Roche’s late-stage portfolio committee, with direct accountability for new formulations and devices, geographic expansion, and post-marketing investments.
GPT-4正在为你翻译摘要中......
